Jim Simons Checkpoint Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.02 - $10.6 $404,827 - $4.21 Million	-396,890 Reduced 52.61%	357,500 $372,000
Q2 2022 Aug 12, 2022	SELL	$0.97 - $1.77 $163,585 - $298,501	-168,645 Reduced 18.27%	754,390 $777,000
Q1 2022 May 13, 2022	BUY	$1.53 - $3.25 $1.07 Million - $2.26 Million	696,535 Added 307.52%	923,035 $1.63 Million
Q4 2021 Feb 11, 2022	BUY	$2.68 - $4.46 $607,020 - $1.01 Million	226,500 New	226,500 $704,000
Q1 2021 May 13, 2021	SELL	$2.6 - $4.16 $72,932 - $116,692	-28,051 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$2.19 - $2.96 $196,769 - $265,953	-89,849 Reduced 76.21%	28,051 $74,000
Q3 2020 Nov 13, 2020	BUY	$1.62 - $4.24 $26,568 - $69,536	16,400 Added 16.16%	117,900 $316,000
Q2 2020 Aug 13, 2020	BUY	$1.19 - $2.27 $66,159 - $126,202	55,596 Added 121.11%	101,500 $201,000
Q1 2020 May 14, 2020	SELL	$1.11 - $2.43 $80,808 - $176,904	-72,800 Reduced 61.33%	45,904 $69,000
Q4 2019 Feb 13, 2020	SELL	$1.18 - $2.39 $9,086 - $18,403	-7,700 Reduced 6.09%	118,704 $204,000
Q3 2019 Nov 13, 2019	SELL	$2.15 - $3.36 $30,745 - $48,048	-14,300 Reduced 10.16%	126,404 $315,000
Q2 2019 Aug 12, 2019	BUY	$2.75 - $5.0 $44,825 - $81,500	16,300 Added 13.1%	140,704 $426,000
Q1 2019 May 14, 2019	BUY	$2.01 - $4.01 $18,893 - $37,694	9,400 Added 8.17%	124,404 $356,000
Q4 2018 Feb 13, 2019	BUY	$1.54 - $3.35 $177,106 - $385,263	115,004 New	115,004 $209,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $351M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.